留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

抗肝纤维化的中药有效成分及其作用机制研究进展

孙蕾,  邓华平,  席忠新,  李霞,  孙连娜

downloadPDF
文章导航 > 药学实践与服务  > 2012 >  30(2): 92-95,127
孙蕾, 邓华平, 席忠新, 李霞, 孙连娜. 抗肝纤维化的中药有效成分及其作用机制研究进展[J]. 药学实践与服务, 2012, 30(2): 92-95,127. doi: 10.3969/j.issn.1006-0111.2012.02.004
引用本文: 孙蕾, 邓华平, 席忠新, 李霞, 孙连娜. 抗肝纤维化的中药有效成分及其作用机制研究进展[J]. 药学实践与服务, 2012, 30(2): 92-95,127. doi: 10.3969/j.issn.1006-0111.2012.02.004
shu
SUN Lei, DENG Hua-ping, XI Zhong-xin, LI Xia, SUN Lian-na. Advances in active ingredients and action mechanism of TCM in treatment of hepatic fibrosis[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(2): 92-95,127. doi: 10.3969/j.issn.1006-0111.2012.02.004
Citation: SUN Lei, DENG Hua-ping, XI Zhong-xin, LI Xia, SUN Lian-na. Advances in active ingredients and action mechanism of TCM in treatment of hepatic fibrosis[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(2): 92-95,127. doi: 10.3969/j.issn.1006-0111.2012.02.004
shu

抗肝纤维化的中药有效成分及其作用机制研究进展

doi: 10.3969/j.issn.1006-0111.2012.02.004
  • 1.

    福建中医药大学药学院, 福建 福州 350108;第二军医大学药学院, 上海 200433

  • 2.

    第二军医大学药学院, 上海 200433

基金项目: 国家重大新药创制专项(2009ZX09502-021).

Advances in active ingredients and action mechanism of TCM in treatment of hepatic fibrosis

  • 1.

    School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350108, China;School of Pharmacy, Second Military Medical University, Shanghai 200433, China

  • 2.

    School of Pharmacy, Second Military Medical University, Shanghai 200433, China

  • 摘要: 肝纤维化是多数慢性肝病所共有的病理特征,肝纤维化逐步发展形成肝硬化,最终导致肝癌。本文将近年报道的具有抗HF作用的中药有效成分作简单综述,归纳为黄酮类、生物碱类、萜类、酚类化合物,并总结了各类有效成分抗HF的作用机制,为深入开展中药抗HF的研究提供一定的参考。
    Abstract: Hepatic fibrosis was the common feature of pathology in almost all patients with chronic liver injury, which led to cirrhosis gradually and liver cancer ultimately. The anti-hepatic fibrosis active ingredients from TCM, including flavones, alkaloids, terpenes and phenols compounds were reviewed with the action mechanism in this paper, which could provide some references for the further study about the anti-hepatic fibrosis of TCM.
  • [1] Lamireau T,Desmouliere A,Bioulac-Sage P,et al.Mechanisms of hepatic fibronegesis[J]. Arch Pediatr, 2002,9(4):392.
    [2] Pinzani M,Rombouts K.Liver fibrosis from the bench to clinical targets[J].Dig Liver Dis, 2004,36(8):231.
    [3] 程 君,杨云霞.黄芩苷对四氯化碳致亚急性肝纤维化小鼠的保护作用[J].华西药学杂志,2010,25(1):32.
    [4] 刘世杰,姜宏齐,马英杰.黄芩苷通过抑制大鼠转化生长因子β1的表达发挥抗肝纤维化作用[J].哈尔滨医科大学学报,2011,45(2):128.
    [5] 王新华,金东岭,何红梅,等.黄芩苷对抗结核药物肝损伤保护作用的实验研究[J].时珍国医国药,2009,20(7):1640.
    [6] 何 蔚,曾 繁.灯盏花素对异丙肾上腺素引起大鼠心肌肥厚和纤维化的保护作用[J].中国药理学通报,2005,21(12):1514.
    [7] 杜钢军,王 梅,林海红,等.灯盏花的肝纤维化保护作用[J].河南大学学报,2009,28(3):170.
    [8] Wilmsen PK,Spada DS,Salvador M.Antioxidant activity of the flavonoid hesperidin in chemical and biological systems[J].J Agric Food Chem,2005,53(12):4757.
    [9] Yeh CC,Kao SJ,Lin CC,et al.The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro[J].Life Sci,2007,80(20):1821.
    [10] 吴芙蓉,李 俊,任丹阳.橙皮苷抗大鼠肝纤维化作用的实验研究[J].安徽医科大学学报,2011,46(4):358.
    [11] 杨慧莹,林克荣.水飞蓟素治疗脂肪肝的作用机制[J].中华现代内科学杂志,2006,3(8):876.
    [12] 曹立波,李 兵,李佐军,等.水飞蓟素对肝纤维化小鼠的保护作用及机制探讨[J].中国药理学通报,2009,25(6):794.
    [13] Tsai JH,Liu JY,Wu TT,et al.Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats[J].J Viral Hepat,2008,15(7):508.
    [14] 王建生,张 海,牛瑞云.苦参素注射液治疗肝纤维化临床探讨[J].实用中西医结合临床,2003,3(4):29.
    [15] 张晓芸,崔晓栋,郭军堂,等.苦参碱对血小板衍生生长因子介导的大鼠肝星状细胞迁移、增殖和凋亡的影响[J].中国慢性病预防与控制,2008,16(4):334.
    [16] 梁建新,屈杏芬,曾文铤,等.氧化苦参碱治疗慢性乙型肝炎肝纤维化的作用机制[J].中国老年学杂志,2010,30(11):1505.
    [17] Shi GF,Li Q.Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo[J].J Nat Med,2011,9(6):0473.
    [18] Cai XH,Wang S,Chen BA.Reseaech advances on the pharmacological effects of tetrandrin[J].World J Gastroenterol,2005,11(2):268.
    [19] Hsu YC,Chiu YT,Cheng CC,et al. Antifibrotic effect of tetrandrine on hepatic stellate cells and rats with liver fibrosis[J].J Gastroen Hepatol,2007,22(1):99.
    [20] 王拥泽,杨宏志,杨沛华.川芎嗪抗肝纤维化作用机制研究[J].河北中医药学报,2006,21(3):8.
    [21] 马 进,郑仕中,陆 茵,等.川芎嗪抑制肝纤维化作用机制的研究进展[J].中国临床药理学杂志,2010,126(5):395.
    [22] Sue YM,Cheng CF,Chang CC,et al.Antioxidation and anti-inflammation by haem oxygenase-1 contribute to protection by tetramethlpyrazine against gentamicin-induced apoptosis in murine renal tubular cells[J].Nephrol Dial Transplant,2009,24(3):769.
    [23] 杨冬娣,刘金元.青蒿琥酯对肝纤维化小鼠肝组织中I型、III型胶原表达的影响[J].河南中医,2009,29(7):654.
    [24] 杨冬娣,刘金元.青蒿琥酯对肝纤维化小鼠肝脏星状细胞凋亡和增生的影响[J].河南中医,2009,29(5):447.
    [25] 来丽娜,杨柳絮,郭春花,等.青蒿琥酯抗大鼠免疫性肝纤维化的作用及机制研究[J].中国药理学通报,2011,27(1):125.
    [26] 沈晓丹,曹 莉,顾 艳,等.蓝萼甲素体外细胞毒活性研究[J].中华中医药学刊,2011,29(6):1334.
    [27] Gao LW,Zhang J,Yang WH,et al.Glaucocalyxin A induces apoptosis in human leukemia HL-60 cells through mitochondria-mediated death pathway[J].Toxicol in Vitro,2011,25(1):51.
    [28] Liu Q,Wang X,Zhang Y,et al.Leukamenin F suppresses liver fibrogenesis by inhibiting both hepatic stellate cell proliferation and extracellar matrix production[J].Acta Pharmacol Sin,2010,31(7):839.
    [29] 徐 标,童巧霞.葫芦素B对小鼠日本血吸虫肝纤维化组织VEGF及氧化应激的影响[J].中药药理与临床,2009,25(6):33.
    [30] 余万贵,张恒文,贺尚荣,等.三七总皂苷对肝纤维化小鼠血清中转化生长因子β1及白介素-1的影响[J].时珍国医国药,2006,17(1):54.
    [31] 曾文勇,石小枫,刘 杞,等.三七总皂苷对肝纤维化大鼠胶原及TGF-β1mRNA表达的影响[J].胃肠病学和肝病学杂志,2010,19(9):795.
    [32] 欧阳灿辉,朱 宣,张焜和,等.熊果酸对肝纤维化大鼠肝组织TGF-β1和α-SMA表达的影响[J].世界华人消化杂志,2009,17(22):2237.
    [33] Asl MN,Hosseinzadeh H.Review of pharmacological effects of Glycyrrhiza sp. and its bioactive comgpounds[J].Phytother Res,2008,22(6):709.
    [34] Moro T,Shimoyama Y,Kushida M,et al.Glycyrrhizin and its metabolite inhibit Smad3-mediated type I collagen gene transcription and suppress experimental murine liver fibrosis[J].Life Sci,2008,83(15-16):531.
    [35] Dang SS,Wang BF,Cheng YA,et al.Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats[J].World J Gastroemterol,2007,13(4):557.
    [36] Fan J,Li X,Li P,et al.Saikaosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury[J].Biochem cell biol,2007,85(2):189.
    [37] Tsai MK,Lin YL,Huang YT.Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats[J].Toxicol Appl Pharmacol,2010,242(2):155.
    [38] Lv Z,Song Y,Xue D,et al.Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells[J].J Ethnophacol,2010,132(2):384.
    [39] Yu MF,Zhou Y,Zheng S,et al.The antifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione inpassaged rat hepatic stellate cells[J].Lab Invest,2006,86(7):697.
    [40] Yasuda Y,Shimizu M,Sakai H,et al.(-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R[J].Chem Biol Interact,2009,182(2-3):59.
    [41] Chávez E,Reyes-Gordillo K,Segovia J,et al.Resveratrol prevents fibrosis,NF-κB activation and TGF-β increases induced by chronic CCl4 treatment in rats[J].J Appl Toxicol,2008,28(1):35.
    [42] Choi JH,Choi CY,Lee KJ,et al.Hepatoprotective effects of an anthocyanin fraction from purple-fleshed sweet potato against acetaminophen-induced liver damage in mice[J].J Med Food,2009,12(2):320.
    [43] Choi JH,Hwang YP,Choi CY,et al.Anti-fibrotic effects of the anthocyanins isolated from the purple-fleshed sweet potato on hepatic fibrosis induced by dimethylnitrosamine administration in rats[J].Food Chem Toxicol,2010,48(11):3137.
    [44] 徐 波,陆 茵,吴佳明,等.姜黄素抗肝纤维化分子机制研究进展[J].中国中医药信息杂志,2008,15(3):9.
    [45] Shu JC,He YJ,Lv X,et al.Curcumin prevents liver fibrosis by including apoptosis and suppressing action of hepatic stellate cells[J].J Nat Med,2009,63(4):415.
    [46] Fu Y,Zheng S,Lin J,et al.Curcumin protects the liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stess and suppressing inflammation[J].Mol Pharmacol,2008,73(2):399.
  • [1] 张晶晶, 索丽娜, 郑兆红.  89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
    [2] 丁华敏, 郭羽晨, 秦春霞, 宋志兵, 孙莉莉.  消风止痒颗粒通过降低白三烯水平对小鼠特应性皮炎急性瘙痒的治疗作用研究 . 药学实践与服务, 2024, 42(5): 211-216. doi: 10.12206/j.issn.2097-2024.202306031
    [3] 李丹, 戴贤春, 王芳珍, 陈奕含, 杨萍, 刘继勇.  HPLC-MS/MS测定当归六黄汤中4种不同成分的含量 . 药学实践与服务, 2024, 42(6): 248-252, 266. doi: 10.12206/j.issn.2097-2024.202305007
    [4] 徐飞, 陈瑾, 鲁育含, 李志勇.  肠道菌群参与糖尿病肾病的机制研究进展 . 药学实践与服务, 2024, 42(5): 181-184, 197. doi: 10.12206/j.issn.2097-2024.202312023
    [5] 杨媛媛, 安晓强, 许佳捷, 江键, 梁媛媛.  正极性驻极体联合5-氟尿嘧啶对瘢痕成纤维细胞生长抑制的协同作用 . 药学实践与服务, 2024, 42(6): 244-247. doi: 10.12206/j.issn.2097-2024.202310027
    [6] 姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量.  巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 1-7. doi: 10.12206/j.issn.2097-2024.202305011
    [7] 景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞.  黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
    [8] 赖立勇, 夏天爽, 徐圣焱, 蒋益萍, 岳小强, 辛海量.  中药青蒿抗氧化活性的谱效关系研究 . 药学实践与服务, 2024, 42(5): 203-210, 216. doi: 10.12206/j.issn.2097-2024.202211012
    [9] 李清, 郭宜银, 陈颖, 瞿发林, 董文燊, 戈煜.  夜宁胶囊对小鼠镇静催眠作用及其机制的研究 . 药学实践与服务, 2024, 42(): 1-4. doi: 10.12206/j.issn.2097-2024.202211047
    [10] 刘丽艳, 余小翠, 孙传铎.  纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202310044
    [11] 修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星.  全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 1-6. doi: 10.12206/j.issn.2097-2024.202312054
    [12] 张林晨, 张小琴, 张俊平.  山楂酸药理作用的研究进展 . 药学实践与服务, 2024, 42(5): 185-189. doi: 10.12206/j.issn.2097-2024.202307052
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  3134
  • HTML全文浏览量:  318
  • PDF下载量:  465
  • 被引次数: 0
出版历程
  • 收稿日期:  2011-09-02
  • 修回日期:  2011-12-21

抗肝纤维化的中药有效成分及其作用机制研究进展

doi: 10.3969/j.issn.1006-0111.2012.02.004
  • 1. 福建中医药大学药学院, 福建 福州 350108;第二军医大学药学院, 上海 200433
  • 2. 第二军医大学药学院, 上海 200433
    • 基金项目:  国家重大新药创制专项(2009ZX09502-021).
  • 收稿日期: 2011-09-02
  • 修回日期: 2011-12-21

摘要: 肝纤维化是多数慢性肝病所共有的病理特征,肝纤维化逐步发展形成肝硬化,最终导致肝癌。本文将近年报道的具有抗HF作用的中药有效成分作简单综述,归纳为黄酮类、生物碱类、萜类、酚类化合物,并总结了各类有效成分抗HF的作用机制,为深入开展中药抗HF的研究提供一定的参考。

English Abstract

孙蕾, 邓华平, 席忠新, 李霞, 孙连娜. 抗肝纤维化的中药有效成分及其作用机制研究进展[J]. 药学实践与服务, 2012, 30(2): 92-95,127. doi: 10.3969/j.issn.1006-0111.2012.02.004
引用本文: 孙蕾, 邓华平, 席忠新, 李霞, 孙连娜. 抗肝纤维化的中药有效成分及其作用机制研究进展[J]. 药学实践与服务, 2012, 30(2): 92-95,127. doi: 10.3969/j.issn.1006-0111.2012.02.004
shu
SUN Lei, DENG Hua-ping, XI Zhong-xin, LI Xia, SUN Lian-na. Advances in active ingredients and action mechanism of TCM in treatment of hepatic fibrosis[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(2): 92-95,127. doi: 10.3969/j.issn.1006-0111.2012.02.004
Citation: SUN Lei, DENG Hua-ping, XI Zhong-xin, LI Xia, SUN Lian-na. Advances in active ingredients and action mechanism of TCM in treatment of hepatic fibrosis[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(2): 92-95,127. doi: 10.3969/j.issn.1006-0111.2012.02.004
shu

    全文HTML

参考文献 (46)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计